BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7769376)

  • 1. Induction of asymptomatic HBeAG carrier state in a patient with Down's syndrome following human bite.
    Kanda T; Hara H; Hanaoka T; Kobayashi I
    J Med; 1994; 25(6):383-7. PubMed ID: 7769376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of serologic response after lamivudine treatment of chronic hepatitis B.
    Dienstag JL; Cianciara J; Karayalcin S; Kowdley KV; Willems B; Plisek S; Woessner M; Gardner S; Schiff E
    Hepatology; 2003 Apr; 37(4):748-55. PubMed ID: 12668966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.
    Fattovich G; Bortolotti F; Donato F
    J Hepatol; 2008 Feb; 48(2):335-52. PubMed ID: 18096267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage.
    Lindh M; Horal P; Dhillon AP; Furuta Y; Norkrans G
    Hepatology; 1996 Sep; 24(3):494-501. PubMed ID: 8781313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome and hepatitis: an evaluation of carrier status.
    Dicks JL; Dennis ES
    J Am Dent Assoc; 1987 May; 114(5):637-9. PubMed ID: 2955013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol consumption and seroconversion from hepatitis B e antigen in the Okinawa Japanese.
    Nomura H; Hayashi J; Kajiyama W; Kashiwagi S
    Fukuoka Igaku Zasshi; 1996 Nov; 87(11):237-41. PubMed ID: 8969539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.
    Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
    J Med Virol; 2004 Oct; 74(2):237-45. PubMed ID: 15332272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B; Nyström J; Björnsdottir T; Lindh G; Hultgren C
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically.
    Song BC; Kim SH; Kim H; Ying YH; Kim HJ; Kim YJ; Yoon JH; Lee HS; Cha CY; Kook YH; Kim BJ
    J Med Virol; 2005 Jun; 76(2):194-202. PubMed ID: 15834881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy.
    Dienstag JL; Schiff ER; Mitchell M; Casey DE; Gitlin N; Lissoos T; Gelb LD; Condreay L; Crowther L; Rubin M; Brown N
    Hepatology; 1999 Oct; 30(4):1082-7. PubMed ID: 10498663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M; Sarin SK; Hissar S; Pande C; Sakhuja P; Sharma BC; Chauhan R; Bose S
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australia antigen in Down's syndrome patients with Robertsonian translocation.
    Tevaluoto-Aarnio M; Hongell K
    Med Biol; 1974 Feb; 52(1):70-1. PubMed ID: 4283654
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: Correlation with viral characteristics.
    Lin HH; Wu WY; Kao JH; Chen DS
    J Gastroenterol Hepatol; 2006 Mar; 21(3):605-9. PubMed ID: 16638107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.